**BREAKING: "Operation Gold Dust" – Whistleblower Leaks Pharma Lobby’s Secret $470M 'Trumprx' Fund to Sink Medicare Negotiations**

BREAKING: “Operation Gold Dust” – Whistleblower Leaks Pharma Lobby’s Secret $470M ‘Trumprx’ Fund to Sink Medicare Negotiations

In a leak that has Washington scrambling, a former senior lobbyist for PhRMA has handed over internal documents detailing a covert slush fund codenamed Trumprx. The objective? To pay off a network of doctors, influencers, and policy think tanks to aggressively push the narrative that previously unaffordable insulin and EpiPens are suddenly “too cheap to trust” if the government talks them down.

The leaked memo, dating from August 2023, boasts that this psychological operation—dubbed “The Razor’s Edge”—would use the former president’s name to create a false dichotomy: either accept his deregulated, patent-extending plan (which keeps prices high but makes the CEO happy), or face a “socialist shortage.” Key passages instruct lobbyists to “re-brand any price cap as a ‘Trumprx’ tax on innovation.”

The twist? The documents suggest the real “Trumprx” is not a policy, but a psychological trap designed to make voters believe lower-cost drugs are a threat—all while the fund’s investors (including three undisclosed family offices tied to hedge funds that short healthcare stocks) pocket the difference. The whistleblower is set to testify to a closed-door Senate committee next week, but not before sharing a single line that sums up the con: “Who benefits? The same people who profit from your pain.”